CG
CORV

Cutler Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Cutler Group’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,368
Closed -$55K – 7117
2017
Q2 		$55K Buy
+12,368
New +$44.9K ﹤0.01% 2410
2017
Q1 		– Sell
-1,409
Closed -$4.16K – 7585
2016
Q4 		$3K Buy
1,409
+600
+74% +$1.72K ﹤0.01% 5465
2016
Q3 		$2K Buy
+809
New +$2.95K ﹤0.01% 5903

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

Cutler Group's CORV Position: Q3 2017 in Review

Cutler Group sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2017, closing a stake of 12,368 shares — an estimated $55K sold.

Cutler Group first reported a position in CORV in Q3 2016 and held it in 3 quarters. The position peaked at $55K in Q2 2017. 31 funds tracked by Wall St. Rank hold CORV as of Q3 2017.

  • Cutler Group reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 12,368 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2017, an estimated $55K.
  • Cutler Group first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2016 and held it in 3 quarters.
  • Cutler Group's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $55K in Q2 2017.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.